NedaRasouliMD
Endocrinology • Aurora, CODiabetes, Lipid Metabolism
Associate Professor, Medicine, University of Colorado School of Medicine
Dr. Rasouli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1997 - 2000
Tehran University of Medical Sciences School of MedicineClass of 1995
Certifications & Licensure
CO State Medical License 2009 - 2025
AR State Medical License 2000 - 2010
MI State Medical License 2000 - 2001
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Most Compassionate Doctor American Registry
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
- Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Tirzepatide for Older Adults with Type 2 Diabetes and Without Obesity: A Post Hoc Analysis of the SURPASS Clinical Trials.Neda Rasouli, John P H Wilding, Anita Y M Kwan, Jim S Paik, Palash Sharma
Diabetes Therapy. 2025-02-28 - Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Compar...Kristina M Utzschneider, Mark Tripputi, Nicole M Butera, Andrea Mari, Samuel P Rosin
Diabetes Care. 2025-02-25 - Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohort.Sun H Kim, Vanita R Aroda, Ranee Chatterjee, Erin S LeBlanc, Jason Nelson
BMJ Open Diabetes Research & Care. 2025-02-20
Journal Articles
- Glycaemic Efficacy and Safety of Linagliptin Compared to Basal‐Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non‐Cardiac Surgery: A Multicenter Ran...Neda Rasouli, MD, Diabetes, Obesity and Metabolism
Press Mentions
The New Penicillin? Pharmacotherapy for ObesityNovember 19th, 2024- Given Shortages, Who ‘Deserves’ Ozempic and GLP-1 Drugs?August 10th, 2024
- Research Helps Show Which Type 2 Diabetes Medication May Work BestJuly 23rd, 2024
- Join now to see all
Grant Support
- Effects Of Insulin Sensitizers And PPAR Ligands On Lipotoxicity In Subjects WithNational Center For Research Resources2006
- Effects Of Insulin Sensitizers On Glucose And Fat Metabolism In Subjects With GENational Center For Research Resources2005–2006
- Effects Of Insulin Sensitizers Of Beta Cell Function And LipotoxicityNational Center For Research Resources2005–2006
- Pathophysiology Of Atypical Diabetes In African Americans: A Pilot ProposalNational Center For Research Resources2004
- Insulin Sensitizers Of Beta Cell Function &LipotoxicityNational Center For Research Resources2004
Committees
- member, Standards of Medical Care in Diabetes - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
